# Zambon SpA clinical trials: 23 on ClinicalTrials.gov (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 23 trials with Zambon SpA as lead sponsor, 0 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Zambon SpA: 23 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/company/zambon-spa

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 23
- Recruiting or not yet: 0
- Read on: November 19, 2026

## Trials

The 23 newest of 23, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| July 16, 2024 | NCT06503770 | A Retrospective Chart Review Study of Patients With CLAD-BOS Post Lung Transplantation | Zambon SpA | Observational | Completed | Bronchiolitis Obliterans Syndrome | 284 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06503770) |
| January 18, 2020 | NCT04229303 | Phase 1 Three Part SAD, MAD & Cross-Over Study of ZP-059 in Healthy and Asthmatic Subjects | Zambon SpA | Phase 1 | Completed | Allergic Bronchopulmonary Aspergillosis | 58 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04229303) |
| September 27, 2019 | NCT04107675 | A Safety Study of Liposomal Cyclosporine A to Treat Bronchiolitis After Hematopoietic Transplant (BOSTON-4) | Zambon SpA | Phase 2 | Terminated | Bronchiolitis Obliterans Syndrome (BOS), GVHD, Chronic, Stem Cell Transplant Complications | 6 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04107675) |
| July 31, 2019 | NCT04039347 | Extension Trial on Efficacy / Safety of L-CsA + SoC in Treating BOS in Post Single or Double Lung Transplant (BOSTON-3) | Zambon SpA | Phase 3 | Terminated | Bronchiolitis Obliterans, Obliterative Bronchiolitis, Bronchiolitis Obliterans Syndrome | 164 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04039347) |
| June 21, 2019 | NCT03994328 | An Observational Study on Safinamide, Rasagiline and Other Standard of Care in PD | Zambon SpA | Observational | Completed | Parkinson's Disease | 1,235 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03994328) |
| June 17, 2019 | NCT03987750 | Safinamide for Levodopa-induced Dyskinesia (PD-LID) | Zambon SpA | Phase 3 | Withdrawn | Dyskinesia, Drug-Induced, Parkinson Disease | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03987750) |
| March 22, 2019 | NCT03887221 | A Single and Multiple Dose Study to Assess How the Drug Enters, Moves Through and Exits the Body, Safety and Tolerability of Safinamide in... | Zambon SpA | Phase 1 | Completed | Healthy | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03887221) |
| March 19, 2019 | NCT03881371 | A Study to Evaluate the Efficacy and Safety of Safinamide, as add-on Therapy, in Idiopathic Chinese Parkinson's Disease (PD) Patients With... | Zambon SpA | Phase 3 | Completed | Parkinson Disease | 307 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03881371) |
| March 19, 2019 | NCT03881163 | A Study to Evaluate Pharmacokinetics, Safety and Tolerability of Single and Multiple Intravenous Doses of N-acetylcysteine (NAC) in Chinese... | Zambon SpA | Phase 1 | Completed | Respiratory Tract Disorders | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03881163) |
| February 18, 2019 | NCT03843541 | A Clinical Trial to Compare the Efficacy and Safety of 1-week Treatment of Intravenous N-acetylcysteine (NAC) 600 mg Twice Daily, Ambroxol... | Zambon SpA | Phase 3 | Completed | Respiratory Tract Diseases, Abnormal Mucus Secretions | 333 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03843541) |
| February 15, 2019 | NCT03841604 | Effect of Safinamide on Parkinson's Disease Related Chronic Pain | Zambon SpA | Phase 4 | Completed | Idiopathic Parkinson Disease | 94 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03841604) |
| November 27, 2018 | NCT03753763 | Safinamide for Multiple System Atrophy (MSA) | Zambon SpA | Phase 2 | Completed | Multiple System Atrophy | 49 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03753763) |
| September 5, 2018 | NCT03657342 | Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Single Lung Transplant (BOSTON-1) | Zambon SpA | Phase 3 | Completed | Bronchiolitis Obliterans, Chronic Rejection of Lung Transplant, Lung Transplant Rejection, Lung Transplant... | 62 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03657342) |
| September 4, 2018 | NCT03656926 | Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Double Lung Transplant (BOSTON-2) | Zambon SpA | Phase 3 | Completed | Bronchiolitis Obliterans, Chronic Rejection of Lung Transplant, Lung Transplant Rejection, Lung Transplant... | 169 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03656926) |
| March 9, 2018 | NCT03460704 | Trial in Non-cystic Fibrosis Bronchiectasis Patients With Chronic Lung Infections Treated With Colistimethate Sodium. | Zambon SpA | Phase 3 | Terminated | Non Cystic Fibrosis Bronchiectasis | 287 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03460704) |
| March 28, 2017 | NCT03093974 | Efficacy and Safety of Inhaled CMS in Bronchiectasis Subjects With Chronic P. Aeruginosa Infection. (PROMIS-I) | Zambon SpA | Phase 3 | Completed | Non Cystic Fibrosis Bronchiectasis | 377 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03093974) |
| December 15, 2016 | NCT02994342 | Efficacy and Tolerability Study of ZP-025 Vaginal Gel for the Treatment of Vaginal Dryness | Zambon SpA | Not applicable | Completed | Vaginal Dryness | 121 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02994342) |
| December 16, 2015 | NCT02631941 | Clinical Study to Evaluate Z7200 Pharmacokinetics Profile | Zambon SpA | Phase 1 | Completed | Asthma | 91 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02631941) |
| July 13, 2015 | NCT02495831 | Drug Interaction Study of Safinamide and a BCRP Substrate, Diclofenac, Concomitantly Administered to Healthy Volunteers | Zambon SpA | Phase 1 | Completed | Healthy | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02495831) |
| October 15, 2014 | NCT02265224 | Bioequivalence Study of Two Different Formulations of N-acetyl-cysteine (NAC) | Zambon SpA | Phase 1 | Completed | no Condition | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02265224) |
| September 11, 2014 | NCT02237508 | A Clinical Study to Evaluate Z7200 (Budesonide/Formoterol) Pharmacokinetics Profile in Healthy Volunteers | Zambon SpA | Phase 1 | Completed | Asthma | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02237508) |
| August 28, 2014 | NCT02227394 | Study to Compare the Effects of Z7200 And Symbicort® Turbohaler on Respiratory Imaging Parameters in Asthmatic Patients | Zambon SpA | Phase 2 | Completed | Asthma, Asthma Chronic, Asthma Bronchial, Asthmatic | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02227394) |
| March 20, 2008 | NCT00639496 | Study of the Effects of High-dose N-acetylcysteine (NAC) in Idiopathic Pulmonary Fibrosis (IPF) | Zambon SpA | Phase 3 | Completed | Pulmonary Fibrosis | 184 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00639496) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 7 |
| Phase 2 | 3 |
| Phase 3 | 9 |
| Phase 4 | 1 |
| Not applicable | 1 |
| Observational | 2 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 19 |
| Terminated | 3 |
| Withdrawn | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Parkinson Disease | 4 |
| Asthma | 4 |
| Bronchiolitis Obliterans | 3 |
| Bronchiolitis Obliterans Syndrome | 3 |
| Rejection, Psychology | 2 |
| Dyskinesia, Drug-Induced | 1 |
| Aspergillosis, Allergic Bronchopulmonary | 1 |
| Multiple System Atrophy | 1 |
| Thyroid Dyshormonogenesis 2A | 1 |
| Respiratory Tract Diseases | 1 |
| Bronchitis | 1 |
| Cystic Fibrosis | 1 |
| Cough | 1 |
| Pulmonary Disease, Chronic Obstructive | 1 |
| Bronchiectasis | 1 |
| Respiration Disorders | 1 |
| Pulmonary Fibrosis | 1 |
| Idiopathic Pulmonary Fibrosis | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Nigerian restaurants in the United States](https://specstream.ai/data/businesses/nigerian-restaurants/united-states)
- [Arabian restaurants in the United States](https://specstream.ai/data/businesses/arabian-restaurants/united-states)
- [Grout companies in the United States](https://specstream.ai/data/businesses/grout-companies/united-states)
- [Siding contractors in the United States](https://specstream.ai/data/businesses/siding-contractors/united-states)
- [Commercial printers in the United States](https://specstream.ai/data/businesses/commercial-printers/united-states)
- [Mortgage brokers in the United States](https://specstream.ai/data/businesses/mortgage-brokers/united-states)
